Lynparza

Active Ingredient(s): Olaparib
FDA Approved: * December 19, 2014
Pharm Company: * ASTRAZENECA LP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lynparza Overview

Olaparib (AZD-2281, MK-7339 trade name Lynparza) is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.[1] In December 2014, olaparib was approved for use as a single agent by the EMA and the FDA.[2][3][4&...

Read more Lynparza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Olaparib

Recent Lynparza Forums: RSS Feed

Confusion, constricted pupils

My friend started taking Lynparza 2 days ago, and is suffering with severe confusion and exhaustion. Her pupils are constricted. Has anyone experienced these symptoms with this med? ## Hello, Ava! How are you? I'm sorry about what your friend is going through. But to be quite honest and realistic, all cancer fighting medications tend to cause some severe and problematic side effects, it's just the nature of the beast, I'm afraid. Everything you listed is included by the manufacturer, Astra Zeneca and the FDA as possible side effects. She may also experience altered sense of taste, heartburn, back pain, diarrhea and loss of appetite. How is she doing?

Updated

Possible Dosages for this and Related Drugs:

Olaparib
  • Capsule: 50mg
  • Tablet: 100mg, 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lynparza: (3 results)

Sorted by National Drug Code
  • 0310-0657 Lynparza 50 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
  • 0310-0668 Lynparza 100 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
  • 0310-0679 Lynparza 150 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp

Other drugs which contain Olaparib or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA